Nasal Cavity Squamous Cell Carcinoma
Associated Genetic Biomarkers
NCI Definition: A squamous cell carcinoma that arises from the nasal cavity mucosa. Signs and symptoms include nasal fullness and obstruction, pain, epistaxis, and the presence of a nasal mass. 
There is 1 clinical trial for nasal cavity squamous cell carcinoma, of which 1 is open and 0 are completed or closed. Of the trial that contains nasal cavity squamous cell carcinoma as an inclusion criterion, 1 is no phase specified (1 open).
CDKN2A and HPV are the most frequent gene inclusion criteria for nasal cavity squamous cell carcinoma clinical trials .
Chemotherapy and intensity-modulated radiation therapy are the most common interventions in nasal cavity squamous cell carcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.